These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8191332)

  • 41. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
    Richardus JH; Vos D; Veldhuijzen IK; Groen J
    J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current seroepidemiology of hepatitis A in Hong Kong.
    Chin KP; Lok AS; Wong LS; Lai CL; Wu PC
    J Med Virol; 1991 Jul; 34(3):191-3. PubMed ID: 1655968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and determinants of hepatitis A virus exposure among prison entrants in Queensland, Australia: implications for public health control.
    Whiteman D; McCall B; Falconer A
    J Viral Hepat; 1998 Jul; 5(4):277-83. PubMed ID: 9751015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changing seroepidemiology of hepatitis A virus infection in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY; Sung JL
    J Med Virol; 1985 Dec; 17(4):297-301. PubMed ID: 3001219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis A, B and C seroprevalence in Pakistan.
    Agboatwalla M; Isomura S; Miyake K; Yamashita T; Morishita T; Akram DS
    Indian J Pediatr; 1994; 61(5):545-9. PubMed ID: 7538098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan.
    Fujisawa T; Kumagai T; Akamatsu T; Kiyosawa K; Matsunaga Y
    Am J Gastroenterol; 1999 Aug; 94(8):2094-9. PubMed ID: 10445533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.
    Vranckx R; Muylle L
    Infection; 1990; 18(6):364-6. PubMed ID: 1963883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A survey on hepatitis A in Portuguese children and adolescents.
    Barros H; Oliveira F; Miranda H
    J Viral Hepat; 1999 May; 6(3):249-53. PubMed ID: 10607238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.
    Arankalle VA; Tsarev SA; Chadha MS; Alling DW; Emerson SU; Banerjee K; Purcell RH
    J Infect Dis; 1995 Feb; 171(2):447-50. PubMed ID: 7844387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of hepatitis A in Mediterranean countries.
    Papaevangelou G
    Vaccine; 1992; 10 Suppl 1():S63-6. PubMed ID: 1335662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017.
    Wang H; Gao P; Chen W; Bai S; Lv M; Ji W; Pang X; Wu J
    Hum Vaccin Immunother; 2019; 15(2):420-425. PubMed ID: 30260275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nationwide Hospital-Based Seroprevalence of Hepatitis A and Hepatitis E Virus in Bangladesh.
    Khan AI; Salimuzzaman M; Islam MT; Afrad MH; Shirin T; Jony MHK; Alam MA; Rahman M; Flora MS; Qadri F
    Ann Glob Health; 2020 Mar; 86(1):29. PubMed ID: 32211299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.
    Dhawan PS; Shah SS; Alvares JF; Kher A; Shankaran ; Kandoth PW; Sheth PN; Kamath H; Kamath A; Koppikar GV; Kalro RH
    Indian J Gastroenterol; 1998 Jan; 17(1):16-8. PubMed ID: 9465507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Seroepidemiologic study of hepatitis A in the community of Madrid during the year 2002].
    Junquera S; Mateos M; Lasa E; Chacón J; Baquero F
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):448-51. PubMed ID: 15482685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposure of Indian children to hepatitis A virus & vaccination age.
    Chadha MS; Chitambar SD; Shaikh NJ; Arankalle VA
    Indian J Med Res; 1999 Jan; 109():11-5. PubMed ID: 10489736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand.
    Poovorawan Y; Vimolkej T; Chongsrisawat V; Theamboonlers A; Chumdermpadetsuk S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):154-7. PubMed ID: 9322299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.